Yale University

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

TitleHIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
Publication TypeJournal Article
Year of Publication2006
AuthorsMay, Margaret T., Jonathan A. C. Sterne, Dominique Costagliola, Caroline A. Sabin, Andrew N. Phillips, Amy C. Justice, François Dabis, John Gill, Jens Lundgren, Robert S. Hogg, Frank de Wolf, Gerd Fätkenheuer, Schlomo Staszewski, Antonella d'Arminio Monforte, and Matthias Egger
Corporate AuthorsAntiretroviral Therapy(ART) Cohort Collaboration
JournalLancet
Volume368
Issue9534
Pagination451-8
Date Published2006 Aug 5
ISSN1474-547X
KeywordsAdolescent, Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Europe, Female, HIV Infections, HIV-1, Homosexuality, Male, Humans, Male, Multicenter Studies as Topic, North America, Prognosis, Risk-Taking, Time Factors
AbstractHighly active antiretroviral therapy (HAART) for the treatment of HIV infection was introduced a decade ago. We aimed to examine trends in the characteristics of patients starting HAART in Europe and North America, and their treatment response and short-term prognosis.
DOI10.1111/j.1530-0277.2011.01601.x
Alternate JournalLancet

External Links